NFKB1 and prostate carcinoma: While previous studies have shown that PKCζ promotes cell survival via activation of NF-κB and acts as a pro-tumorigenic gene in pancreatic cancer and prostate cancer cells, more recent studies have demonstrated that PKCζ acts as a versatile tumor suppressor, especially in the intestine [53–56].